Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2016

Nov 1, 2016

35146_dirs_2016-11-01_4d150c1c-6046-431a-ba83-d68cd08cd489.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2016-10-31

Reporting Person: MCCANEY FRANK J (Director, President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-10-31 Stock Option (right to buy) $0.55 A 542500 Acquired 2026-10-31 Common Stock (542500) Direct

Footnotes

F1: Mr. McCaney received stock options to purchase up to 542,500 shares of the Company's common stock, which vests in three substantially equal installments on October 31, 2017, October 31, 2018 and October 31, 2019